IPO registrations (S-1, F-1) · Registrants

ALDER BIOPHARMACEUTICALS INC

SEC CIK
1423824 · filings on EDGAR ↗
Registration
Form S-1, first filed 2014-03-19, last 2015-01-08; 2 initial registrations, 4 amendments
Outcome
Final prospectus filed 2014-05-08; declared effective 2014-05-07
Industry (SIC)
Pharmaceutical Preparations 2834
Business address
11804 NORTH CREEK PARKWAY SOUTH, Bothell, WA 98011
EIN
90-0134860
EDGAR entity type
operating
Insiders and CEO pay
ALDER BIOPHARMACEUTICALS INC on the corporate pages

Offering terms

Proposed price range
$13.00–$15.00 per share (S-1/A filed 2014-05-01)
Final price
$10.00 per share, below the range (424B4 filed 2014-05-08, an initial public offering)
Shares sold
8,000,000
Gross proceeds
$80,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ALDR
Lead underwriters
Credit Suisse; Leerink Partners
Syndicate
Wells Fargo; Sanford C. Bernstein

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 11

FiledFormWhat it isName as filedEDGAR
2014-03-19S-1S-1 (registration)ALDER BIOPHARMACEUTICALS INC0001193125-14-104868 ↗
2014-04-25S-1/AS-1/A (amendment)ALDER BIOPHARMACEUTICALS INC0001193125-14-158365 ↗
2014-05-01S-1/AS-1/A (amendment)ALDER BIOPHARMACEUTICALS INC0001193125-14-177343 ↗
2014-05-07S-1MEFS-1MEF (added securities)ALDER BIOPHARMACEUTICALS INC0001193125-14-188165 ↗
2014-05-07EFFECTEFFECT (declared effective)ALDER BIOPHARMACEUTICALS INC9999999995-14-001359 ↗
2014-05-08424B4424B4 (final prospectus)ALDER BIOPHARMACEUTICALS INC0001193125-14-190254 ↗
2014-12-22S-1S-1 (registration)ALDER BIOPHARMACEUTICALS INC0001193125-14-450716 ↗
2015-01-05S-1/AS-1/A (amendment)ALDER BIOPHARMACEUTICALS INC0001193125-15-001743 ↗
2015-01-08S-1/AS-1/A (amendment)ALDER BIOPHARMACEUTICALS INC0001193125-15-004290 ↗
2015-01-08424B4424B4 (final prospectus)ALDER BIOPHARMACEUTICALS INC0001193125-15-005060 ↗
2015-01-08EFFECTEFFECT (declared effective)ALDER BIOPHARMACEUTICALS INC9999999995-15-000063 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-05-01S-1/Aregistration statement$13.00–$15.007,150,000-Nasdaq ALDR4primary document; range, shares headline, cover names 4document ↗
2014-05-08424B4final prospectus$10.008,000,000$80,000,000Nasdaq ALDR4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BAYLESS JON WOther; TenPercentOwner42014–2015
Benedict LarryOfficerEVP and PAO; Sr. VP Finance142014–2019
Bisgaard PeterDirector12014
BOCHNOWSKI JAMES JTenPercentOwner22014
BONDERMAN DAVIDTenPercentOwner22014
Bridger GaryDirector; TenPercentOwner62014–2015
COULTER JAMES GTenPercentOwner22014
Davidson AaronDirector22014
DELPHI BIOINVESTMENTS VII LPTenPercentOwner22014
Delphi Management Partners VII, L.L.C.TenPercentOwner22014
DELPHI VENTURES VII L PTenPercentOwner22014
DOMENIK STEPHEN LOther; TenPercentOwner42014–2015
DOUGLASS DAVID LTenPercentOwner22014
DOW STEPHEN MDirector; Director,TenPercentOwner112014–2017
H.I.G. Venture Partners II, L.P.TenPercentOwner22014
H.I.G. Ventures - Alder, LLCTenPercentOwner22014
JAGGERS JOHN VOther; TenPercentOwner42014–2015person page Fuzzy
KIMZEY JACKIE ROther; TenPercentOwner42014–2015
Latham John AOfficerChief Scientific Officer362014–2019
Litton Mark JamesOfficerChief Business Officer252014–2018
McLean David J.Other; TenPercentOwner42014–2015
Montgomery Alan BruceDirector82014–2019
Novo A/STenPercentOwnerOther22014
OXAAL JOHN TOther; TenPercentOwner42014–2015
PAKIANATHAN DEEPIKADirector; Director,TenPercentOwner82014–2018
Preston HeatherDirector52014–2019
ROEDER DOUGLAS ATenPercentOwner22014
Schatzman Randall CDirector,OfficerPresident and CEO212014–2018
SCHUELE ALAN ROther; TenPercentOwner42014–2015
Sevin Rosen Fund IX L.P.Other; TenPercentOwner62014–2015
Sevin Rosen IX Affiliates Fund L.P.Other; TenPercentOwner62014–2015
SIEGALL CLAY BDirector102014–2019
Smith Jeffrey T LOfficerManaging Director; Sr. VP Translational Medicine392014–2019
SRB Associates IX L.P.Other; TenPercentOwner62014–2015
STURIALE NICHOLAS GOther; TenPercentOwner42014–2015
TPG Group Holdings (SBS) Advisors, Inc.TenPercentOwner22014
Ventures West 8 Limited PartnershipTenPercentOwner22014
Hassler RandalOfficerEVP, Pharmaceutical Ops.; SVP, Manufacturing; SVP, Pharmaceutical Ops102014–2019
Cleveland Paul BDirector; Director,OfficerInterim President and CEO82015–2019
Carter Paul RutherfordDirector72015–2019
Bucher James BOfficerEVP & General Counsel; Sr. VP & General Counsel92016–2019
Whitaker Timothy MOfficerChief Medical Officer32016–2017
Sandoval ElisabethOfficerCCO & EVP, Corporate Strategy; Chief Commercial Officer52016–2018
YARNO WENDY LDirector72017–2019
Lavelle ErinOfficerChief Commercial Officer; Chief Operating Officer52018–2019
Carter Eric GOfficerInterim Chief Medical Officer22018
Green JeremyDirector; TenPercentOwner92018–2019
Redmile Group, LLCDirector92018–2019
Azelby RobertDirector,OfficerPresident and CEO52018–2019
Campoy CarlosOfficerChief Financial Officer32018–2019
STRECK PAULOfficerChief Medical Officer42019
Dac NadiaOfficerChief Commercial Officer32019
H LUNDBECK A STenPercentOwner22019

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2018-01-26ALDER BIOPHARMACEUTICALS INCBiotechnology$260,341,000$99,999,95261

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorLUNDBECK SEATTLE BIOPHARMACEUTICALS, INC.WAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerALDER BIOPHARMACEUTICALS INCWAForm D private offeringsCIK (EXACT)
Patent assigneeALDER BIOPHARMACEUTICALS, INC.WAPatents (USPTO)name and state
SEC filerALDER BIOPHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerAlder BioPharmaceuticals, Inc.WATrademarks (USPTO)name and state
Form 5500 plan sponsorLUNDBECK SEATTLE BIOPHARMACEUTICALS, INC.EIN (EXACT)
Person pageJohn V JaggersPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, WA first:

More with this interest.

In other datasets, the same topic (Health) in WA:

Interests: Pharmaceutical Preparations · Health